he U.S. Supreme Court unanimously ruled Monday that biotech drug copies -- called biosimilars -- can become available to consumers quicker. Writing for the court, Associate Justice Clarence Thomas said that the decision was not based on policy arguments, but rather, the "plain language" of the biosimilar statue itself.

More at: http://www.upi.com/Top_News/US/2017/...6071497289238/